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Randomized controlled trial comparing treatment
outcome of two compression bandaging systems
and standard care without compression in patients
with venous leg ulcers
Irene K. Y. Wong, PhD,a Anneke Andriessen, PhD,b Diana T. F. Lee, PhD,c David Thompson, PhD,d
Lau Yun Wong, MD,e David V. K. Chao, MD,f Winnie K. W. So, PhD,g and M. Abel, PhD,h Hong Kong;
Malden, The Netherlands; and Leicester, United Kingdom
Background: Compression therapy is not common for venous leg ulcer patients in Hong Kong.
Methods: This randomized controlled trial compared the clinical effectiveness of compression bandaging using four-layer
bandaging (4LB) or short-stretch bandaging (SSB) and usual care (moist wound healing dressing without compression).
The 24-week study looked at venous leg ulcer patients aged>60 years in a community setting. The primary parameter was
time to ulcer healing. Secondary parameters were ulcer area and pain reduction comparing week 0 (start) vs week 24
(end), measuring results per group and between groups. Intention-to-treat analysis involved descriptive statistics,
survival analysis, and repeated measures analysis of variance. The log-rank test was used for univariable analysis. All
withdrawn patients had a negative outcome score over the whole study duration.
Results:Of 321 patients who received randomized treatment, 45 (14%) did not complete the 24-week study period. At 24
weeks, Kaplan-Meier analysis on healing time was statistically significant (P < .001) in favor of the compression groups.
The mean (SD) healing time in the SSB group (9.9 [0.77]) was shorter than that of the 4LB group (10.4 [0.80]) and the
usual care group (18.3 [0.86]). Pain reduction was significant (P < .001) for the compression-treated groups only.
Conclusions: Compression bandaging was more effective than usual care without compression. Both compression systems
TE
Dwere safe and feasible for venous ulcer patients in a community setting in Hong Kong. (J Vasc Surg 2012;55:1376-85.)
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ACChronic venous insufficiency, a consequence of lowerextremity valvular reflux or venous obstruction, or both,produces hypertension in the dermal microcirculation.1,2The result is inflammation, leading to ulceration.3,4 Venous
ulcers (VUs) can vary in size and can be difficult to manage,
particularly if they are painful, complicated with dermatitis,
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1376r if they drain profusely.5,6 The chronicity of VUs, to-
ether with high recurrence rates, creates a challenge to
orkload and health care expenses and impedes patients’
hysiologic and psychosocial well-being.6,7
Compression bandaging is the standard treatment for
Us, although it is not widely known and practiced in
ong Kong.8Wong et al9 indicate that this approach is not
opular in Hong Kong, where patients generally receive
aily wound dressing changes at general outpatient clinics
GOPC). Further, little attention has been paid to identi-
ying the underlying cause of VUs and current trends in leg
lcer treatment.9,10
Previous studies have confirmed that the proportion of
omplete ulcer healing is improved with therapy using high
ompression compared with no compression.11-13 Com-
ression is directed at lowering venous hypertension, in-
reasing wound cleansing, and enhancing tissue vascular-
zation.12 When comparing the effectiveness of different
igh-compression bandage systems, such as the four-layer
andage (4LB) compression system and short-stretch ban-
age (SSB) compression system, mixed outcomes on the
uperiority of either system are shown from published
tudies.11-13 Although a meta-analysis showed a shorter
ealing time for 4LB, the trials that included SSB looked at
arious short stretch systems with a variety of properties.14
he effects of compression bandaging on the pain severity
nd pain interference are essential influences on patient
oncordance with therapy.6,7
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ATo evaluate efficacy and feasibility of compression ther-
apy as a standard measure for elderly patients with venous
leg ulcers, a study was designed to provide information that
will be used to implement compression therapy for these
patients in Hong Kong. The study compared treatment
outcome using two different systems of compression ban-
daging that are currently considered the mainstay for pa-
tients with venous leg ulcers. A third group (control group)
was treated with a moist wound healing dressing and no
compression, which is the current standard of care in Hong
Kong. This would not be considered ethically acceptable in
most countries, where compression is the standard care for
venous leg ulcers.
METHODS
Research design
Treatment was administered individually to the partic-
ipants15 for 24 weeks. This interval was used because it is
described in the guidelines of the International Compres-
sion Club as an appropriate study period, especially in an
elderly venous leg ulcer population.15 For the randomized
controlled trial, a three-group pretest and repeated posttest
design was used to assess the effects of compression ban-
daging on promoting ulcer healing. After pretest measure-
ments were taken, the computer-generated randomization
schedule was used to allocate patients to one of the treat-
ment groups.
After confirming eligibility of a patient and obtaining
informed consent, the clinical investigator digitally received
the information on the allocation of the patient to one of
the treatment groups. Posttest measurements were col-
lected at 12 and 24 weeks after the participants received
randomized treatment. The clinical assessor was blinded for
the treatment given, as was the person who performed the
statistical analysis.
Patient selection. This study was conducted in a com-
munity setting in GOPCs in the New Territories East
Cluster, Kowloon East Cluster, and the Kowloon Central
Cluster, with a total of nine GOPCs in three clusters.
Inclusion criteria. Men and women aged 55 years
with venous leg ulcers confirmed by vascular assessment (ie,
Doppler) entered the study. Appropriate vascular studies
(ankle-brachial index of 0.75 or a normal pulse volume
recording) were obtained to exclude peripheral arterial
disease. CEAP classification was used. The CEAP classifi-
cation system for chronic venous disorders takes into ac-
count clinical, etiologic, anatomic, and pathophysiologic
factors. Its informative value has been validated. The
wound bed was free from necrotic tissue, and patients were
able to understand and communicate in Cantonese.
Exclusion criteria. Patients with VUs of 5 cm2 or
118 cm2, with an ulcer duration of 4 weeks or 1 year
were excluded, as were patients with two or more leg ulcers
on one or both legs. Also excluded were those with an
allergy to one of the used materials, severe systemic dis-
eases, acute superficial or deep vein thrombosis, arterial
RE
TRocclusive disease (stadium II, III, or IV; ankle-brachial nndex, 0.8), and those with concurrent administration of
rugs that might affect ulcer healing, such as corticoste-
oids or chemotherapeutics.
Demographic and clinical data. The Modified Park-
ide Health Trust Leg Ulcer Record was used for demo-
raphic and clinical data collection. Data included age, sex,
edical history, current treatment, ulcer assessment, limb
erfusion, vascular assessment, and vascular conditions.16
rimary outcome measure
Time to ulcer healing. The Verge Videometer (Vista
edical Ltd, Winnipeg, Manitoba, Canada) was used to
ssess reduction in ulcer area, comparing baseline vs results
t 12 weeks and 24 weeks (end). It is a digital planimetry
ool used to measure and document ulcer dimensions and
lcer stage. The inter-rater reliability is 0.98 for the surface
rea and 0.99 for the circumference.17
econdary outcome measures
Reduction of ulcer area. The same tool as described
or measuring time to healing was used for assessing ulcer
rea reduction.
Ulcer-related pain. The Chinese version of the Brief
ain Inventory (BPI) was used to measure the intensity of
ain and its interference in the patient’s life (reactive di-
ension). It also queries the patient about pain relief, pain
uality, and patient perception of the cause of pain. The
PI is a powerful tool, and having demonstrated both
eliability and validity across cultures and languages, it is
eing adopted in many countries for clinical pain assess-
ent, epidemiologic studies, and in studies of the effective-
ess of pain treatment. The BPI consists of 15 items,
ncluding pain prevalence, location, intensity, treatment,
nd interference assessment; however, only the pain scores
ere used. The coefficient  was 0.894 for pain severity
tems and 0.915 for and pain interference items.18,19
Ulcer assessment and progress report. A self-developed
reatment record was used to record ulcer progress, type
nd quantity of dressing material used, and the duration
nd frequency of visits.19
Interface pressure. Interface pressure was recorded
ndividually to ensure an adequate and consistent pressure
ange in both groups 40 mm Hg, measured on applica-
ion of the compression bandages with the patient supine.
his pressure range is considered as strong pressure.20-23
ressure levels were also recorded with the patient stand-
ng, and the static stiffness index (SSI), the difference
etween standing and supine pressure,20-23 was calculated.
ll measurements were repeated before bandage removal
o be sure that the pressure remained in the therapeutic
ange over time. Interface pressure was measured with a
alidated pneumatic device with a flat probe that can stay in
lace under the bandage for 1 week (Picopress, Microlabi-
alia, Padua, Italy).22 The probe was placed at the B1 point,
ocated at the medial aspect of the leg, where the gastroc-
C
EDemius tendon turns in its muscular part.22
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Data analysis
Intention-to-treat analysis was performed. Descriptive
statistics were used to analyze demographic and clinical
data.
Primary outcome measure. Healing time was ana-
lyzed over the 24-week study period,15 calculating Kaplan-
Meier survival curves and using the log-rank test for uni-
variable analysis. Meanwhile, the Cox proportional hazard
model was used to compare the healing time between
treatments, adjusting for potential confounders, such as
baseline covariates, that are unbalanced between treatment
groups. Interim analysis for time to ulcer healing at 12
weeks was not conducted.
Secondary outcome measures. Repeated-measures
analysis of variance (RMANOVA) was used to compare the
differences in ulcer area reduction per group at week 0
(start), week 12, and at week 24 (end). Age, ulcer duration,
and ulcer size were controlled in the analysis using the
Mauchly test. All withdrawal cases were scored as having a
negative treatment outcome for the entire study period.
Patients were considered treatment failures if they made
any treatment changes, prematurely discontinued random-
ized treatment for any reason, or had missing data for the
evaluation(s). RMANOVA was also used to compare the
differences in ulcer-related pain among the three treatment
groups across the 24-week study period.
Sample size. To obtain 80% statistical power with a
0.05 significance level, to detect a 20% difference or more
between groups on healing time, ulcer area and pain reduc-
tion, comparing week 0 (start) vs week 24 (end) results, a
sample size of 321 (107 in each group) was necessary to
establish clinical efficacy superiority of compression treat-
ment vs no compression in venous leg ulcer patients. The
hazard ratio was 0.57. The sample size allowed for a 20%
dropout rate in each group.
Compression bandaging materials. This random-
ized controlled trial compared the clinical effectiveness of
the 4LB system (Profore; Smith and Nephew PLC, Hull,
UK) with the SSB system (Rosidal Sys; Lohmann &
Table I. Dressing protocol applied for the study
Indication Light
Standard situation
Aim Maintain MWH
Primary dressing Biocellulose
Secondary dressing Film
Contaminated wounds, high bacterial
burden
Aim Reduce bacterial count,
maintain MWH
Primary dressing Biocellulose  PHMB
Secondary dressing Absorbent
MWH, Moist wound healing; PHMB, polyhexamethylene biguanide.
RE
TRRauscher GmbH, Rengsdorf, Germany) and usual care tmoist wound healing dressing, no compression) on time
o healing and ulcer-related pain in patients with VUs in a
ommunity setting. Depending on the amount of exudate
roduced, the compression bandages are typically applied
n weekly intervals by trained clinicians.12,14,24
The moist wound healing dressings applied consisted
f alginates and foams as well as a Hydrobalance dressing
Suprasorb A and Suprasorb P, Suprasorb X; Lohmann &
auscher GmbH, Rengsdorf, Germany) and were used
ccording to the treatment recommendation as reported in
able I.
Clinicians involved in the study treatment received
raining on the use of the dressings and the compression
herapy. Patients who participated in the experimental
roups received compression bandaging with 4LB or SSB
long with the usual topical ulcer care, which comprised
oist wound healing dressings. The control group partic-
pants received no compression, but only a moist wound
ealing dressing, usual care (UC) in Hong Kong, at the
ime the study was conducted.8,9 Ethical approval was
btained by the university.
ESULTS
haracteristic of the sample
A total of 380 patients were recruited at nine GOPCs
rom May 2007 to November 2008; 59 patients were later
xcluded. This study included 321 VU patients for the
omparison of clinical efficacy of SSB, 4LB, and UC. For
he patient Consolidated Standards of Reporting Trials
CONSORT) flow diagram, see Fig 1.25 Forty-five patients
14%) were withdrawn before the second data collection at
eek 24. The reasons for withdrawal are summarized in
able II.
No serious adverse events were noted during the study
eriod. Adverse events were noted related to the treatment:
6 in the 4LB group, 10 in the SSB group, and 11 in the
C group; however, the difference was not significant. No
easonal influence on patient withdrawal was observed
Wound exuding status
Moderate Heavy
aintain MWH and exudate
absorption
Exudate absorption
iocellulose Alginate
oam Absorbent pad or foam
educe bacterial count, maintain
MWH and exudate absorption
Reduce bacterial burden and
exudate absorption
iocellulose  PHMB Alginate silver
bsorbent Absorbent pad
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4LB, Four-layer bandage; SSB, short-stretch bandage.
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As reported in Table III, 206 participants (64.2%) were
en, 217 (67.6%) were married, and 239 (74.5%) reached
he primary educational level. The mean age was 71.7 (SD,
.5) years. Seventy patients (21.8%) were living alone, 175
54.5%) were retired, and 89 (27.7%) were receiving finan-
ial support from the Comprehensive Social Security Assis-
ance.
Table IV presents the participants’ clinical characteris-
ics, and Table V reports the baseline outcome variables of
articipants who completed and withdrew from the study.
he three study groups were homogenous in all sociode-
ographic and clinical characteristics. At the first data
ollection, the three groups demonstrated no significant
tatistical differences in any of the key outcome variables:
lcer size, pain severity, and pain interference. This may
eflect the success of random assignment and demonstrated
hat homogeneity was unaffected by the patients who with-
rew.
rimary parameter
Time to ulcer healing. The Kaplan-Meier survival
nalysis included all 321 patients. All withdrawn patients
ere scored as having a negative treatment outcome for the
ntire study duration. Fig 2 illustrates the Kaplan-Meier
ited from 
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Study related adverse 
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5 UC n=91 
SORT) flow diagram for patients in the study. 4LB,
our-layer bandage; MWH, moist wound healing; SSB,
CT
EDN=380 subjects recru
nine GOPCs
N=59 exclude
4 LB n=107 SSB n=107
Pre test 
Post test 
Withdrawn n=17 
Study related adverse 
events n=16, not study 
related n=1 
Withdrawn n=
Study related ad
events n=10, not
related n=2
Finalized N=
(14% discontinued
4 LB n=90 SSB n=9
Fig 1. Consolidated Standards of Reporting Trials (CON
Four-layer bandage; GOPC, general outpatient clinics. 4LB, FTable II. Reasons and number of withdrawals
Adverse event
Experimental groups,
No. (%)
ControlSSB 4LB
(n  107) (n  107) (n  107)
Related to the
randomized
treatment
Pain 3 5 1
Restricted ankle
movement 2 5 1
Itching 2 2 1
Too much warmth 1 2 0
Wound infection 0 0 1
Massive amount of
exudates 1 1 1
Sensitive to bandage 0 1 0
Severe ankle edema 0 0 1
Increased ulcer size 1 0 5
Total, No. (%) 10 (9.34) 16 (14.95) 11 (10.28)
Related to other reasons
Hospitalization due to
medical conditions 1 1 2
Loss of contact 1 0 3
Total 12 17 16
RE
TRurves for time to complete ulcer healing and withdrawn
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Variablea
Total
Experimental groups
ControlSSB 4LB
(n  321) (n  107) (n  107) (n  107)
Age, years
Mean  SD 71.7  8.5 71.7  8.5 71.7  8.5 71.7  8.5
Median (range) 73 (60-84) 75 (60-84) 74 (60-78) 68 (60-76)
Sex
Male 206 (64.2) 68 (21,0) 68 (21.0) 70 (22.2)
Female 115 (35.8) 39 (12.5) 39 (12.5) 36 (10.8)
Educational level
No formal education 82 (25.5) 28 (8.7) 27 (8.4) 27 (8.4)
Primary, 1-6 years 157 (49.0) 52 (16.0) 52 (16.0) 53 (17)
Secondary, 7 years 82 (25.5) 27 (8.3) 27 (3.8) 28 (8.9)
Marital status
Single 49 (15.3) 16.3 (5.0) 16.3 (5.0) 16.4 (5.3)
Married 217 (67.6) 70.0 (20.5) 72.0 (20.5) 75.6 (26.6)
Widow/widower 51 (15.9) 17 (5.3) 17 (5.3) 17 (5.3)
Divorced 4 (1.2) 2 (0.6) 1 (0.3) 1 (0.3)
Living arrangements
Living alone 70 (21.8) 24 (7.6) 23 (7.1) 23 (7.1)
Living with spouse only 81 (25.2) 27 (8.4) 27 (8.4) 27 (8.4)
Living with family 170 (53.0) 57 (17.9) 56 (17.2) 57 (17.9)
Employment status
Employed 111 (34.6) 37 (11.5) 37 (11.5) 37 (11.5)
Unemployed 35 (10.9) 11 (3.2) 12 (3.8) 12 (3.8)
Retired 175 (54.6) 58 (18.2) 58 (18.2) 58 (18.2)
Source of income
CSSA 90 (27.6) 30 (9.2) 30 (9.2) 30 (9.2)
Salary 100 (31.2) 33 (10.2) 33 (10.2) 34 (10.8)
Others 132 (41.1) 44 (13.7) 44 (13.7)CT
ED
4LB, Four-layer bandage; CCSA, Comprehensive Social Security Assistance scheme; SD, standard deviation; SSB, short-stretch bandage.
aCategoric data are expressed as number (%) and continuous data as indicated.Table IV. Clinical characteristics of the consenting participants
Variablea
Experimental groups
SSB 4LB Control Total
(n  107) (n  107) (n  107) (n  321)
Hypertension 35 (10.0) 35 (10.0) 36 (13.0) 106 (33.0)
Diabetes mellitus 12 (3.2) 10 (2.8) 7 (3.0) 29 (9.0)
Heart disease 14 (4.1) 8 (2.6) 8 (2.6) 30 (9.3)
Respiratory disease 9 (3.9) 7 (2.8) 7 (2.8) 23 (7.2)
Receives pain-relief meds 38 (13.1) 37 (10.9) 37 (10.9) 112 (34.9)
Body mass index, kg/m2 23.0  4.5 22.0  4.2 23.0  4.6 23.0  4.5
Underweight, 18.5 55 (17.1)
Normal, 18.6-24.9 148 (46.1)
Overweight, 25-29.9 101 (31.5)
Obese 30 9 (2.8)
Ulcer duration, months 32.4  41.7 28.4  42.5 27.4  43.7 27.4  43.7
Ulcer size, cm2 7.56  10.43 7.54  9.95 9.23  12.50 8.2  11.0
Circumference, cm
Ankle 23.9  2.8 21.9  2.7 22.7  2.8 23.9  2.8
Calf 35.5  5.3 32.5  5.1 33.5  5.8 35.5  5.3
Ulcer site
Right malleolus 26 (8.2) 24 (7.5) 23 (7.0) 73 (22.7)
Right gaiter area 24 (7.4) 24 (7.4) 24 (7.4) 72 (22.2)
Left malleolus 33 (11.2) 32 (9.5) 32 (9.5) 97 (30.2)
Left gaiter area 26 (8.2) 26 (8.2) 26 (8.2) 79 (24.6)
RE
TR
A4LB, Four-layer bandage; SSB, short-stretch bandage.
aCategoric data are expressed as number (%) and continuous data as mean  standard deviation.
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Apatients in all groups. The treatment period was estimated
from the date the randomized treatment was started (base-
line, week 0) up to 24 weeks. The Kaplan-Meier curves
exhibited a statistically significant difference in the time to
complete ulcer healing (P .001) in favor of SSB and 4LB,
compared with UC. The mean (SD) time to ulcer healing
was 9.8 (0.77) weeks for SSB, 10.4 (0.80) weeks for 4LB,
and 18.3 (0.86) weeks for UC.
Subgroup analyses were performed to compare the
time to ulcer healing among the three groups. Both groups
treated with compression demonstrated highly significant
differences (both P .001) compared with the UC group.
However, no significant difference was observed between
the SSB and 4LB groups (P  .57).
Themean healing of ulcers at week 12 was 66.4% (71 of
107) for those treated with SSB, 59.8% (64 of 107) for
those treated with 4LB, and 28.0% (30 of 107) for UC. At
week 24, 72.0% (77 of 107) of the patients treated with
SSB, 67.3% (72 of 107) with 4LB, and 29.0% (31 of 107)
with UC achieved ulcer healing.
Secondary parameters
Reduction in ulcer area. The reduction in ulcer area
was followed up at weeks 12 and 24 and was compared with
baseline (week 0). The mean (SD) ulcer areas for patients
treated with SSB, 4LB, and UC at baseline were 7.56
(10.43), 7.54 (9.95), and 9.23 (12.50) cm2, respectively,
and was not statistically significantly different (ANOVA,
P  .493).
Fig 3 demonstrates the reduction in ulcer area over the
study period. At week 12, the mean (SD) ulcer area was
reduced to 3.00 (8.40) cm2 for SSB, to 3.48 (8.54) cm2 for
4LB, and to 7.54 (12.45) cm2 for UC. The reduction in
mean ulcer area among the three intervention groups from
baseline to week 12 was highly significant (P .001 for all
groups), with greater reductions in the SSB and 4LB
groups. At week 24, the mean (SD) ulcer area had further
reduced to 2.85 (8.18) for SSB, 3.39 (8.64) for 4LB, and 6.90
(10.62) cm2 for UC groups. The reduction in ulcer area from
week 12 to 24was not significant in the 4LBgroup (P .67) or
theUCgroup(P .16),buta statistically significant reduction in
Table V. Baseline outcome variables of the participants w
Outcome variablesa
Scoreb Com
(range)
Ulcer size, cm2 7.8 
Pain (BPI-C)
Pain severity 0-10 3.0 
Functional status (FAI-C)
Total 0-45 38.9 
Domestic chores 0-15 15.7 
Leisure/work 0-15 9.8 
Outdoor activities 0-15 13.4 
BPI-C, Brief Pain Inventory (Chinese version); FAI-C, Frenchay Activities
aCategoric data are expressed as mean  standard deviation (range).
bPossible score range of the scale.
cP  .01.
RE
TRulcer area was observed in the SSB group (P .047). URMANOVA was conducted to compare the change in
lcer size among the three groups in a 24-week period.
ge, ulcer duration, and ulcer size were controlled in the
nalysis. The assumption of sphericity was violated under
he Mauchly test (P  .001), which meant the equality of
ariances among the three groups could not be assumed.
herefore, the most conservative approach of the lower-
ound test was used to compare the significance of time
ffects. The interaction effect between time and interven-
ion was statistically significant (P  .003), so the time
rends among the three groups did not reflect a parallel
elationship. It can be concluded that the rates of reduction
n ulcer sizes in the SSB group and 4LB groups are greater
han that in the UC group.
Interface bandage pressure. The pressure range pro-
ided by the compression bandages was consistent for all
atients that were assessed: mean (SD) 53.7 (7.5) mm Hg
n the SSB group vs 51.1 (6.8) mm Hg in the 4LB group,
easured with patients supine, and 68.5 (8.5) mm Hg in
he SSB group and 46.7 (7.5) mm Hg in the 4LB group,
easured with patients standing. Measurements before
andage removal showed that the mean (SD) pressure
ropped significantly in both groups to 29.8 (3.7) mm Hg
n the SSB group and 28.9 (4.7) mmHg in the 4LB group,
ut the pressure measured in standing patients remained in
he therapeutic range 40 mm Hg when measured in
tanding patients, at 45.8 (4.6) mm Hg in the SSB group
nd 43.9 (4.4) mm Hg in the 4LB group.
The SSI was 10 in compression groups, as noted for
he SSI range of inelastic bandages and systems that have a
ohesive bandage as an outer layer. The SSI remained in
his range for 1 week, the duration of bandage application,
espite bandage pressure loss.
Ulcer-related pain severity. Pain severity was as-
essed at the start of the intervention, before removal of the
oiled dressing and bandages. Patients scored on a 10-point
isual analog scale as 0 (painless) to 10 (most painful) the
our items of the BPI instrument. These pain scores were
ollected at weeks 0, 12, and 24. The average (SD) pain
everity score among patients treated with SSB, 4LB, and
mpleted and who were withdrawn from the study
the study Withdrawn from study
Pc276) (n  45)
10.5  10.0 .140
(0-10) 3.4  1.8 .187
(15.0-54.0) 36.0  9.6 .037
14.8  5.3 .263
8.8  2.7 .057
12.4  3.3 .048
(Chinese version).
CT
EDho co
pleted
(n 
11.1
1.9
8.2
4.8
3.0
2.7
IndexC at baseline (week 0) was 3.32 (2.03), 3.03 (1.62), and
a
s
t
r
w
age; S
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among the three groups (ANOVA P  .238).
Fig 4 illustrates the change in pain severity scores across
the time points. At week 12, the average (SD) pain severity
scores were reduced to 1.25 (1.84), 1.43 (1.77), and 2.61
(2.40), respectively, for the the SSB, 4LB, and UC groups.
Fig 2. A, Time to ulcer healing: 321 patients were inc
compression-treated groups demonstrated significant dif
healing, showing the withdrawals. 4LB, Four-layer bandRE
TRReductions in pain severity scores from baseline to week 12 rmong the SSB group and the 4LB group were highly
ignificant (all P .001); however, this was not the case for
he UC group (P  .253). Therefore, the superior pain
eductions were significantly evident in patients treated
ith compression bandaging.
At week 24, the average (SD) pain severity scores
in the Kaplan-Meier survival estimate, which for both
ces vs usual care (for both *P  .001). B, Time to ulcer
SB, short-stretch bandage.
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Arespectively, for the SSB, 4LB, and UC groups. Reductions
in pain severity scores from weeks 12 to 24 in the three
groups were not statistically significant (all P  .05).
RMANOVA was conducted to compare the change in pain
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Fig 3. Differences in ulcer area reduction at 12 weeks and at 24
weeks were assessed by repeated-measures analysis of variance. The
reduction in ulcer area in all three groups comparing week 0 (start)
vs week 12 was significant (all P  .001), with superior results for
the short-stretch bandage (SSB) and four-layer bandage (4LB)
groups. At week 24, the reduction in ulcer area was statistically
significant only for SSB (*P  .04).
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Fig 4. Repeated-measures analysis of variance was used to assess (A)
pain severity and (B) interference analysis. Reductions in pain severity
scores comparingweek0 vsweek12 for short-stretchbandage (SSB) and
four-layerbandage(4LB)were significant (*P .001)andnot significant
for the usual-care group (P .253). Pain interference had significantly
reduced for all three groups (P .005).
RE
TRseverity scores among the three groups in a period of 24 teeks, controlled for age, ulcer duration, and ulcer size.
he interaction effect between time and intervention was
tatistically significant (P  .001). Thus, it can be con-
luded that the rates of reduction in pain severity scores in
he SSB and 4LB groups were superior to UC.
omparison of material and personnel costs
Costs were calculated for weekly bandage changes for
he SSB and 4LB groups.12 For the 4LB patients, one kit is
equired every week because this is a disposable, single-use
ystem.12 For the SSB patients, one kit suffices for the
4-week treatment period.12 The foam underpadding ma-
erial and the compression bandages may be washed at
0°C. The skin protection and fixation bandage used in this
ystem are single-use and are supplied in the kit in adequate
uantities for a 24-week application of the compression
andages. Costs for compression per healed VU for a
2-week treatment period was 78  107/71  €117.55
or SSB and 348  107/64  €581.81 for the 4LB group.
osts for compression per healedVU for a 24-week treatment
eriod was 78  107/77  €108.39 for SSB and 696 
07/72  €1034.30 for the 4LB, providing significant ma-
erials cost savings for the patients treated with SSB (Fig 5).
imitations
A detailed interim analysis of the 12-week study results
n time to VU healing was not in the scope of the study.
owever, an analysis on ulcer area and pain reduction was
onducted at 12 and at 24 weeks.
ISCUSSION
Compression bandaging and VU healing. The re-
ults of this study were obtained from 321 patients with one
nilateral VU. The sample size allowed for a 20% dropout
cope, which was not reached. No severe adverse events
ere reported during the study. The withdrawal rate was
1.2% in the SSB group, 15.9% in the 4LB group, and
7.1% in the UC group. The present study confirms the use
f compression bandaging is superior compared with UC
ithout compression in promoting ulcer healing under a
tandardized modern wound management guideline. In
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ig 5. Costs of compression bandaging per healed ulcer compar-
ng the four-layer (4LB) and short-stretch bandage (SSB) systems.
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A12 weeks, and this was 29.0% at 24 weeks vs both compres-
sion groups, where ulcer healing progressed also in this
period. In the control group, five patients were withdrawn
due to an increased ulcer size and one patient due to severe
ankle edema. In the compression-treated groups, the rea-
sons for withdrawal were mostly patient tolerance issues,
such as pain and itching. The reasons for withdrawal noted
in the UC group may be directly related to chronic venous
hypertension, for which accepted treatment is compression.
As to a difference between SSB and 4LB, published
studies report various results. Previous studies comparing
compression and no compression are quite outdated.26-29
Moreover, these studies were conducted with small sample
sizes, each ranging from 17 to 42 individuals. The only
exception was theMorrell et al,29 where approximately 116
patients were included in each group. A meta-analysis com-
paring 4LB and SSB demonstrated superior results for
healing time for the 4LB patients in the seven studies that
were included.14 However, a variety of SSB systems were
used in the studies, with different modes of application and
under varying padding materials.14 Further, pressure levels
that were achieved during the study were not monitored.
The definition used for SSB is unclear, where 4LB is a single
system, which is well defined. For this reason, pressure
levels should be monitored when conducting clinical trials
to ensure that the compression system that is used is a
system with sufficient stiffness.16,20,21,30 A recent study on
a SSB system similar to the one used in our study, which
measured sub-bandage pressure and healing rates, demon-
strated similar results as were obtained in our study.24
One major difference between the 4LB and SSB is the
elasticity of the single components. Whereas the 4LB con-
tains layers with long-stretch properties (extensibility
100%), the SSB consists of short-stretch materials (exten-
sibility 70%). By applying the elastic components of the
4LB in several layers over each other, the final bandage will
become more stiff due to the friction between the layers,
impeding the extension of the bandage when the leg cir-
cumference increases during standing or walking.20
Finally, the present study showed that the SSB-treated
group demonstrated material cost savings for both a 12-
week and 24-week treatment period with once-weekly
dressing and bandage changes.
Compression bandaging and pain reduction. Com-
pression reduces venous reflux and reduces leg edema by
removing the fluid from the interstitial tissues into the
venous system.10 This reduction in edema likewise reduces
stimulation to the peripheral nerve endings, thus lowering
the level of nociceptive pain.6 All of these factors directly
improve the patient’s well-being and quality of life. How-
ever, the effect of VU healing contributes to the overall
improvement, as reduction in ulcer area reduces pain.6 Our
study results are in line with these findings.
Compression bandaging and implications for practice.
The identification of risk factors may support faster healing;
however, it is complex to determine these risk factors.31
Compression bandaging in VU care is both a science and an
RE
TRart.7,8 The use of compression bandaging is a challenge forll parties concerned. Therefore, it is necessary to develop
ffective management strategies that may not induce pain,
ffect the quality of life, and alter the patient’s functional
tatus.6,32 For compression bandaging to be effective, a
horough assessment of the underlying ulcer pathology and
ffect on the patient’s life must be conducted, and staff
eeds to be trained to be able to apply compression ade-
uately.10,16,20,21,30,31
ONCLUSIONS
On the basis of the present study’s results, it is statisti-
ally significantly evident that using compression with SSB
r 4LB is more effective than UC without compression.
he findings of the present study informed the allocation of
ealth resources and the development of a specialized nurs-
ng service for the community setting. Compression ther-
py is now being implemented for patients receiving venous
eg ulcer care in Hong Kong.
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